Orchid Pharma Limited (NSE:ORCHPHARMA)
India · Delayed Price · Currency is INR 777.10
-15.40 (-1.94%)
Jun 1, 2026, 3:30 PM IST
Orchid Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 205.47 | 996.57 | 921.67 | 463.18 | -19.51 |
Depreciation & Amortization | 354.53 | 343.77 | 321.07 | 547.79 | 869.93 |
Other Amortization | - | 1.69 | 11.31 | 0.08 | 0.31 |
Loss (Gain) From Sale of Assets | -79.28 | 3.2 | 1.88 | -399.85 | -0 |
Loss (Gain) From Sale of Investments | - | - | - | -0.15 | -5.12 |
Loss (Gain) on Equity Investments | 6.61 | -38.99 | 28.98 | 21.54 | 35.23 |
Provision & Write-off of Bad Debts | 6.85 | 68.41 | -2.65 | 11.88 | 36.67 |
Other Operating Activities | -3.67 | -97.17 | 56.05 | 329.54 | 298.27 |
Change in Accounts Receivable | -140.94 | -490.66 | 196.47 | -416.54 | -229.19 |
Change in Inventory | 699.6 | -621.45 | -354.88 | -560.82 | 25.37 |
Change in Accounts Payable | 61.04 | -67.82 | 548.51 | 139.14 | 473.63 |
Change in Other Net Operating Assets | -98.25 | 94.61 | -468.48 | 47.59 | 325.86 |
Operating Cash Flow | 1,012 | 192.15 | 1,260 | 183.38 | 924.75 |
Operating Cash Flow Growth | 426.64% | -84.75% | 587.05% | -80.17% | 292.07% |
Capital Expenditures | -3,836 | -1,501 | -648.15 | -849.13 | -144.04 |
Sale of Property, Plant & Equipment | 90.48 | - | - | 585.46 | 0.99 |
Divestitures | - | - | - | - | 1,594 |
Investment in Securities | 786.75 | 1,044 | -2,592 | -53.07 | -326.55 |
Other Investing Activities | 105.84 | 187.39 | 120.02 | 4.61 | 4.88 |
Investing Cash Flow | -2,853 | -269.32 | -3,120 | -312.14 | 1,129 |
Long-Term Debt Issued | 1,847 | 285.56 | - | 1,732 | 199.99 |
Total Debt Issued | 1,847 | 285.56 | - | 1,732 | 199.99 |
Short-Term Debt Repaid | -128.52 | - | - | - | - |
Long-Term Debt Repaid | - | -2.21 | -2,200 | -1,098 | -2,048 |
Total Debt Repaid | -128.52 | -2.21 | -2,200 | -1,098 | -2,048 |
Net Debt Issued (Repaid) | 1,719 | 283.35 | -2,200 | 633.92 | -1,848 |
Issuance of Common Stock | - | - | 3,919 | - | - |
Other Financing Activities | -18.95 | -31.13 | -48.96 | -322.26 | -320.12 |
Financing Cash Flow | 1,700 | 252.22 | 1,670 | 311.66 | -2,168 |
Net Cash Flow | -140.99 | 175.05 | -189.96 | 182.91 | -113.87 |
Free Cash Flow | -2,824 | -1,309 | 611.77 | -665.75 | 780.71 |
Free Cash Flow Growth | - | - | - | - | 239.71% |
Free Cash Flow Margin | -33.36% | -14.20% | 7.47% | -10.00% | 13.95% |
Free Cash Flow Per Share | -55.66 | -25.81 | 12.65 | -16.31 | 19.13 |
Cash Interest Paid | - | 31.13 | 48.96 | 322.26 | 320.12 |
Cash Income Tax Paid | - | 9.37 | -6.29 | 2.99 | 19.06 |
Levered Free Cash Flow | -1,391 | -749.27 | -2,498 | -1,048 | 2,206 |
Unlevered Free Cash Flow | -1,308 | -658.4 | -2,396 | -846.73 | 2,406 |
Change in Working Capital | 521.44 | -1,085 | -78.38 | -790.62 | 595.66 |